Pre-market
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX-V/RKV

Rakovina Therapeutics Inc (RKV : TSX-V)

Common Stock

$0.32

CAD

+0.10 (45.45%)

Last updated: 2026-09-08

Get RKV alerts:

RKV

Rakovina Therapeutics Inc

Source:WealthAwesomeWealthAwesome
$0.20 (166.67%)
30 day period
$0.10$0.21$0.32Jul 22Aug 13Sep 8

Performance

1 Day

+45.45%

1 Week

+42.22%

1 Month

+146.15%

YTD

+220.00%

Key Statistics

Market Cap

$5.37M

52W High

$0.44

52W Low

$0.09

P/E Ratio

-

50 Day MA

$0.15

200 Day MA

$0.13

Beta

-0.22

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/8/2026$0.22$0.32$0.22$0.32$0.32168,944
9/4/2026$0.22$0.22$0.22$0.22$0.222,000
9/2/2026$0.23$0.23$0.22$0.22$0.2227,000
9/1/2026$0.23$0.23$0.20$0.23$0.2318,100
8/31/2026$0.23$0.23$0.17$0.17$0.1712,613
8/28/2026$0.22$0.22$0.22$0.22$0.22500
8/26/2026$0.18$0.23$0.18$0.21$0.2174,001
8/25/2026$0.20$0.20$0.20$0.20$0.2032,000
8/24/2026$0.20$0.20$0.20$0.20$0.202,946
8/21/2026$0.15$0.20$0.15$0.19$0.193,000

Analyst Price Targets

Based on analyst covering RKV

📉

Wall Street analysts forecast RKV stock price to fall 21.9% over the next 12 months.

Consensus

Bearish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.25

-21.9% Upside

Current Price

C$0.32

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on RKV's historical volatility

HistoricalForecast68%95%
C$0.04C$0.81C$1.58C$2.35C$3.12C$3.90TodayApr 24Jun 29Sep 8Oct 21Dec 4Jan 16

30-Day Vol

191.7%

Annualized

90-Day Vol

151.6%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$0.38

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.34C$0.18C$0.66
60 trading daysC$0.36C$0.14C$0.92
90 trading daysC$0.38C$0.12C$1.20

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Rakovina Therapeutics Inc

Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments that target DNA-damage response systems. It develops kt-2000 series, which are patented class of oral, small molecule PARP inhibitors with established in vitro and in vivo proof of concept; kt-3000 series drug candidates, which are bi-functional targeted small molecules designed to inhibit both PARP and histone deacetylase; and kt-4000 series, which are small molecules engineered to induce targeted DNA damage in tumor cells. The company is also involved in the development of kt-5000 series of brain-penetrant dual ATR"mTOR inhibitor drug candidates. It has a strategic collaboration with Variational AI Inc. to develop AI-generated ATR inhibitor compounds; and a non-binding Letter of Intent to form a joint venture to co-develop AI-discovered small-molecule oncology therapies. The company was formerly known as Vincero Capital Corp. Rakovina Therapeutics Inc. is headquartered in Vancouver, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-7.11M
Profit Margin
0.00%
ROE (TTM)
-891.37%
EPS (Diluted)
-0.41
Book Value
0.01

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About RKV

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
CES-PCelestial Acquisition Corp.$0.20+185.71%
DDDMetavista3D Inc.$0.36+78.05%
SHRXSharp Therapeutics Corp.$1.37+50.55%
SRAStria Lithium Inc$1.15+47.44%
ATR-PAster Acquisition Corp.$0.10+46.15%
AAAJ-PAAJ Capital 3 Corp.$0.04+40.00%
FRNTFRNT Financial Inc$0.06+37.50%
PHDProvidence Gold Mines$0.06+37.50%

RKV.V news timeline

4 articles covering RKV.V, most recent first

Latest

Why Rakovina Therapeutics Inc stock surged yesterday

Stocks

Advertisement